Literature DB >> 12547591

The adjuvant OM-174 induces both the migration and maturation of murine dendritic cells in vivo.

Bernard Pajak1, Virginie Garze, Gwyn Davies, Jacques Bauer, Muriel Moser, Carlo Chiavaroli.   

Abstract

The aim of this study was to test the capacity of the novel adjuvant OM-174, a lipid A analog, to induce the migration and the maturation of murine dendritic cells (DC) in vivo, a step which is considered as the initiation of the adaptive immune response. BALB/c mice were injected intravenously or subcutaneously with OM-174. The spleen and popliteal lymph nodes were harvested, and analyzed for DC localization and phenotype. The data presented here clearly show that, OM-174 induces the migration of DC from the periphery to the T cell areas of lymphoid organs, and their maturation into cells expressing high levels of MHC class II and co-stimulatory molecules, with a potency close to that of Escherichia coli lipopolysaccharide (LPS).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12547591     DOI: 10.1016/s0264-410x(02)00529-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

Review 1.  Controlling immune responses by targeting antigens to dendritic cell subsets and B cells.

Authors:  Craig P Chappell; Natalia V Giltiay; Christiane Dresch; Edward A Clark
Journal:  Int Immunol       Date:  2013-11-27       Impact factor: 4.823

Review 2.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis.

Authors:  L Chatenoud; S You; H Okada; C Kuhn; B Michaud; J-F Bach
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

3.  CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells.

Authors:  Shu-Ling Fu; Chun-Cheng Lin; Ming-Ling Hsu; Sheng-Hung Liu; Yu-Chuen Huang; Yu-Jen Chen
Journal:  Oncotarget       Date:  2016-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.